Loop F D, Lytle B W, Cosgrove D M, Sheldon W C, Irarrazaval M, Taylor P C, Groves L K, Pichard A D
Am J Cardiol. 1979 Aug;44(2):195-201. doi: 10.1016/0002-9149(79)90304-7.
Three hundred consecutive patients received coronary arterial bypass grafts as treatment for stenosis of the left main coronary artery. Ostial stenosis was more prevalent among women (P less than 0.001). Operative (hospital) mortality was 4 percent (12 of 300). Among 148 survivors who underwent recatheterization after a mean interval of 16.5 months, the graft patency rate was 88 percent. After a minimal follow-up period of 49 months and a mean interval of 69 months, 75 percent of the survivors were asymptomatic and 94 percent were employed or fully active. The actuarial 5 year survival rate was 88.2 percent. The presence of right coronary artery disease, abnormal preoperative ventricular function and incomplete revascularization adversely affected survival, but the differences did not reach statistical significance. Comparison of this long-term follow-up study with controlled and noncontrolled studies of nonsurgical treatment of obstructions of the left main coronary artery indicates that myocardial revascularization alleviates cardiac symptoms and increases life expectancy in patients with severe atherosclerosis of this artery.
连续300例患者接受冠状动脉搭桥术治疗左主干冠状动脉狭窄。开口处狭窄在女性中更为常见(P<0.001)。手术(住院)死亡率为4%(300例中有12例)。在平均间隔16.5个月后接受再次导管检查的148名幸存者中,移植血管通畅率为88%。经过至少49个月的随访期和平均69个月的间隔,75%的幸存者无症状,94%的幸存者就业或完全活动。5年精算生存率为88.2%。右冠状动脉疾病、术前心室功能异常和血管重建不完全对生存有不利影响,但差异未达到统计学意义。将这项长期随访研究与左主干冠状动脉阻塞非手术治疗的对照和非对照研究进行比较表明,心肌血管重建可缓解心脏症状并提高该动脉严重动脉粥样硬化患者的预期寿命。